Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank86
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-49.10M
↑ 66% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-143.90M
Historical baseline
PeriodValueYoY Change
TTM$-49.10M+81.2%
2024$-261.52M-64.4%
2023$-159.05M+6.3%
2022$-169.80M-24.3%
2021$-136.57M-10.0%
2020$-124.19M+50.5%
2019$-250.95M-501792.0%
2018$-50000.00-